Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists

BACKGROUND: Concerns for hyperkalaemia limit the use of mineralocorticoid receptor antagonists (MRAs). The frequency of MRA‐associated hyperkalaemia in real‐world settings and the extent of subsequent MRA discontinuation are poorly quantified. METHODS AND RESULTS: Observational study including all S...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Heart Fail
Main Authors: Trevisan, Marco, de Deco, Pietro, Xu, Hairong, Evans, Marie, Lindholm, Bengt, Bellocco, Rino, Barany, Peter, Jernberg, Tomas, Lund, Lars H., Carrero, Juan J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2018
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607478/
https://ncbi.nlm.nih.gov/pubmed/29667759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.1199
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados